Aphria Inc.
Special Committee concludes that acquisition of LATAM assets was within an acceptable range as compared to similar acquisitions by competitors Review also involved independent physical inspection of operating LATAM assets, confirming facilities, licenses and employment ... [Read]
Pivot Pharmaceuticals Inc
Formulated Using Pivot's Thrudermic™ Transdermal Nanotechnology VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE:PVOT / OTCQB:PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has completed the development of a controlled-release transdermal patch ... [Read]